Does Medicare Cover Repatha? Understanding Your Options for High Cholesterol Treatment

Introduction: Navigating Repatha Coverage with Medicare

Managing high cholesterol is a critical component of preventing serious cardiovascular events like heart attacks and strokes. For many individuals, lifestyle changes and statin medications are effective. However, some patients, particularly those with very high cholesterol levels, familial hypercholesterolemia, or established atherosclerotic cardiovascular disease (ASCVD), may require more advanced treatments. Repatha (evolocumab) is one such medication, a powerful PCSK9 inhibitor designed to significantly lower LDL ("bad") cholesterol.

Given the high cost of specialized medications like Repatha, understanding how Medicare covers this drug is a paramount concern for beneficiaries. Medicare's complex structure, with its various parts and plans, can make determining coverage challenging. This comprehensive guide will break down Medicare's coverage for Repatha, helping you understand which parts apply, what costs to expect, and how to navigate the process to ensure you get the treatment you need.

We'll delve into the specifics of Medicare Part D (prescription drug plans), Medicare Part B (medical insurance), and Medicare Advantage (Part C) plans, exploring the nuances of formularies, prior authorization, and financial assistance programs. Our goal is to provide a clear, factual, and actionable roadmap for Medicare beneficiaries considering or currently using Repatha.

What is Repatha (Evolocumab)?

Repatha is a biologic medication that belongs to a class of drugs known as PCSK9 inhibitors. PCSK9 (proprotein convertase subtilisin/kexin type 9) is a protein that regulates the number of LDL receptors on liver cells. By inhibiting PCSK9, Repatha allows more LDL receptors to remain on the liver's surface, which in turn helps the liver remove more LDL cholesterol from the blood.

How Repatha Works

Repatha is administered via subcutaneous injection (under the skin), typically once every two weeks or once a month. It works by blocking the PCSK9 protein, which otherwise would degrade LDL receptors. With more LDL receptors available, the liver can efficiently clear LDL cholesterol particles from the bloodstream, leading to a significant reduction in LDL-C levels.

Who is Repatha For?

Repatha is approved for several indications, primarily targeting individuals who need substantial LDL cholesterol reduction beyond what statins can achieve or who cannot tolerate statins:

• Adults with established atherosclerotic cardiovascular disease (ASCVD): This includes individuals with a history of heart attack, stroke, or peripheral artery disease, for whom Repatha can reduce the risk of future cardiovascular events.
• Adults with primary hyperlipidemia (including heterozygous familial hypercholesterolemia, HeFH): For patients who require additional LDL-C lowering.
• Adults and adolescents aged 10 years and older with homozygous familial hypercholesterolemia (HoFH): A rare genetic disorder causing extremely high cholesterol levels from birth.

Repatha is often prescribed in conjunction with diet and other lipid-lowering therapies, such as statins.

Understanding Medicare: The Basics

Before diving into Repatha coverage, it's essential to understand the different parts of Medicare:

• Medicare Part A (Hospital Insurance): Covers inpatient hospital stays, skilled nursing facility care, hospice care, and some home health care.
• Medicare Part B (Medical Insurance): Covers certain doctor's services, outpatient care, medical supplies, and preventive services.
• Medicare Part C (Medicare Advantage): An alternative to Original Medicare (Parts A and B) offered by private companies approved by Medicare. These plans cover everything Original Medicare covers and often include additional benefits like prescription drug coverage, vision, dental, and hearing.
• Medicare Part D (Prescription Drug Coverage): Helps cover the cost of prescription drugs. It's offered by private insurance companies approved by Medicare.
• Medigap (Medicare Supplement Insurance): Private insurance that helps pay for some of the costs that Original Medicare doesn't cover, like copayments, coinsurance, and deductibles. Medigap plans generally do not cover prescription drugs.

Does Medicare Part D Cover Repatha?

For most Medicare beneficiaries, Repatha coverage primarily falls under Medicare Part D Prescription Drug Plans. Part D plans are offered by private insurance companies and have their own formularies (lists of covered drugs).

Formularies and Tiers

Every Part D plan has a formulary. Repatha, being a specialty medication, is typically found on a higher tier of a plan's formulary. Drugs on higher tiers usually come with higher out-of-pocket costs (copayments or coinsurance).

• Formulary: A list of prescription drugs covered by a Part D plan. Plans must cover a range of drugs in most therapeutic categories, but they don't all cover every drug.
• Tiers: Drugs on a formulary are often categorized into tiers, each with a different cost-sharing level. Specialty drugs like Repatha are often on Tier 4 or 5, meaning higher out-of-pocket expenses.

It is crucial to check the specific formulary of any Part D plan you are considering to ensure Repatha is covered and to understand its tier placement.

Prior Authorization and Step Therapy

Because Repatha is a high-cost specialty medication, Part D plans almost always require specific utilization management restrictions before covering it. These commonly include:

• Prior Authorization (PA): Your doctor must submit a request to your Part D plan, providing medical justification for why Repatha is necessary for your condition. This typically involves documenting your diagnosis, previous treatments (e.g., maximum tolerated statin therapy), and lab results (e.g., LDL-C levels).
• Step Therapy: Many plans require you to try less expensive, equally effective drugs (like statins) first. If those medications are ineffective or cause intolerable side effects, then the plan may approve coverage for Repatha.

Navigating these requirements can be complex, and it often requires close collaboration between you, your doctor, and your insurance plan.

The Part D Coverage Phases and Costs

Medicare Part D coverage involves several phases, each affecting your out-of-pocket costs:

1. Deductible Phase: You pay the full cost of your medications until you meet your plan's deductible. In 2024, the maximum deductible for Part D plans is $545, but many plans have lower or no deductibles.
2. Initial Coverage Phase: After meeting your deductible, you pay a copayment or coinsurance for your drugs, and your plan pays the rest. This phase continues until your total drug costs (what you and your plan have paid combined) reach a certain limit ($5,030 in 2024).
3. Coverage Gap (Donut Hole): Once you and your plan have spent a combined amount on covered drugs that reaches the initial coverage limit, you enter the coverage gap. In this phase, you are responsible for a larger percentage of your drug costs. For most drugs, you pay 25% of the cost, and the manufacturer pays a discount of 70% (which counts toward your out-of-pocket maximum), while your plan pays 5%. This phase continues until your out-of-pocket spending reaches the catastrophic coverage threshold.
4. Catastrophic Coverage Phase: Once your out-of-pocket spending (which includes your deductible, copayments, coinsurance, and the manufacturer discount in the donut hole) reaches a certain threshold ($8,000 in 2024), you enter catastrophic coverage. In this phase, you pay nothing for covered Part D drugs for the remainder of the year. Historically, there was a small copay or coinsurance, but the Inflation Reduction Act of 2022 eliminated out-of-pocket costs in the catastrophic phase starting in 2024.

Repatha's high cost means that many beneficiaries will likely reach the coverage gap and potentially the catastrophic phase within a year, especially without financial assistance.

Does Medicare Part B Cover Repatha?

While less common for Repatha, there are specific circumstances where Medicare Part B Medical Insurance might cover the drug. Part B typically covers drugs that are administered by a healthcare professional in an outpatient setting, such as a doctor's office or hospital outpatient clinic.

Repatha is usually self-administered via an auto-injector at home. However, if a patient requires the drug to be administered by a doctor or other medical professional in a clinical setting (e.g., due to inability to self-inject, specific medical need, or for initial training/observation), Part B might cover it. This is a rare scenario for Repatha.

If Repatha were covered under Part B, you would typically pay 20% of the Medicare-approved amount after meeting your Part B deductible. Part B coverage is generally more predictable than Part D, as there are no formularies or coverage gaps.

Medicare Advantage Plans (Part C) and Repatha

Medicare Advantage Plans (Part C) are offered by private insurance companies and are an alternative to Original Medicare. Most Medicare Advantage plans include prescription drug coverage (MAPD plans).

If you are enrolled in a Medicare Advantage plan that includes Part D coverage, Repatha coverage will follow the rules of that specific plan's formulary, including prior authorization, step therapy, and cost-sharing structures similar to standalone Part D plans. The key difference is that your medical and drug benefits are bundled into one plan.

It's crucial to review the Evidence of Coverage and formulary for your specific Medicare Advantage plan to understand Repatha coverage and costs, as they can vary significantly between plans and providers.

Cost Considerations and Financial Assistance for Repatha

Repatha is an expensive medication, and even with Medicare coverage, out-of-pocket costs can be substantial. Understanding the list price and available assistance programs is vital.

List Price of Repatha

The wholesale acquisition cost (WAC), or list price, of Repatha can be upwards of $5,000 to $6,000 per year, depending on the dosage and frequency. While this isn't what most people pay directly due to insurance negotiations, it highlights why coverage is so important.

Manufacturer Patient Assistance Programs

Amgen, the manufacturer of Repatha, offers a patient assistance program called Amgen Assist. This program can help eligible patients with their out-of-pocket costs, including deductibles, copayments, and coinsurance. Eligibility usually depends on income, insurance status, and other criteria. It is highly recommended to explore this option if you are prescribed Repatha.

Medicare Low-Income Subsidy (LIS) or "Extra Help"

For Medicare beneficiaries with limited income and resources, the federal government offers the Low-Income Subsidy (LIS), also known as "Extra Help." This program helps pay for Part D premiums, deductibles, and copayments. If you qualify for Extra Help, your Repatha costs could be significantly reduced, even during the coverage gap.

State Pharmaceutical Assistance Programs (SPAPs)

Some states offer their own Pharmaceutical Assistance Programs to help residents with prescription drug costs. These programs can vary widely by state in terms of eligibility and benefits. Check with your state's health department or Area Agency on Aging to see if such a program exists where you live.

Appealing Coverage Decisions

If your Medicare Part D plan denies coverage for Repatha, you have the right to appeal the decision. The appeals process typically involves several levels:

1. First-Level Appeal (Redetermination): You or your doctor can request your plan to reconsider its decision.
2. Second-Level Appeal (Independent Review Entity): If the plan upholds its denial, you can appeal to an independent review organization.
3. Further Appeals: There are additional levels of appeal, including administrative law judge hearings and federal court review, if necessary.

It's important to work closely with your prescribing doctor throughout the appeals process, as they can provide critical medical documentation to support your case.

When to See a Doctor

If you have concerns about your cholesterol levels or cardiovascular health, it's crucial to consult with a healthcare professional. Here are some situations when you should see a doctor:

• Routine Check-ups: Regular physical exams often include cholesterol screenings, especially as you age or if you have risk factors for heart disease.
• High Cholesterol Diagnosis: If you've been diagnosed with high cholesterol, your doctor can discuss lifestyle modifications and medication options like statins.
• Uncontrolled High Cholesterol: If your LDL cholesterol levels remain high despite lifestyle changes and maximum tolerated statin therapy, your doctor might consider advanced treatments like Repatha.
• Familial Hypercholesterolemia (FH): If you have a family history of very high cholesterol or early heart disease, you should be screened for FH. Repatha is a key treatment for many FH patients.
• Established Cardiovascular Disease: If you've had a heart attack, stroke, or have other forms of ASCVD, your doctor will work with you to aggressively manage your cholesterol to prevent future events.
• Questions About Medicare Coverage: If you are prescribed Repatha and have questions about your Medicare coverage, your doctor's office staff or a Medicare counselor can help you navigate the process.

Always discuss all your treatment options, potential side effects, and financial concerns with your healthcare provider.

Frequently Asked Questions (FAQs) About Repatha and Medicare

Q: What is Repatha used for?

A: Repatha is used to lower LDL (